Purification of polyclonal antibodies from Cohn fraction II plus III, skim milk, and whey by affinity chromatography using a hexamer peptide ligand

被引:34
作者
Menegatti, Stefano [1 ]
Naik, Amith D. [1 ]
Gurgel, Patrick V. [1 ]
Carbonell, Ruben G. [1 ]
机构
[1] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA
关键词
Affinity chromatography; Immunoglobulin G; Milk; Peptide ligands; Plasma; HUMAN-IMMUNOGLOBULIN G; HUMAN PLASMA; PROTEIN-A; THERAPEUTIC ANTIBODIES; VIRUS; AUTOIMMUNE; SEPARATION; EFFICACY; DISEASES; YIELD;
D O I
10.1002/jssc.201200199
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
HWRGWV, a peptide that binds specifically to the Fc fragment of human immunoglobulin G (IgG), was used for the purification of IgG from Cohn fraction II + III of human plasma and from bovine skim milk and whey. The concentration of sodium chloride and sodium caprylate in the binding buffer as well as the pH of the elution buffer were optimized to achieve high IgG yield and purity. Under optimized conditions, IgG was recovered from plasma fractions with yield and purity up to 84% and 95%, respectively. IgG was also purified from skim milk with 74% yield and 92% purity and from whey with 85% yield and 93% purity. Purification experiments were also performed with Protein A resin and the results were found to be similar to those obtained with the peptide adsorbent.
引用
收藏
页码:3139 / 3148
页数:10
相关论文
共 50 条
[1]   Therapeutic applications of monoclonal antibodies [J].
Berger, M ;
Shankar, V ;
Vafai, A .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (01) :14-30
[2]   Therapeutic monoclonal antibodies [J].
Breedveld, FC .
LANCET, 2000, 355 (9205) :735-740
[3]   Therapeutic antibodies for human diseases at the dawn of the twenty-first century [J].
Brekke, OH ;
Sandlie, I .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :52-62
[4]   Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use [J].
Brorson, K ;
Brown, J ;
Hamilton, E ;
Stein, KE .
JOURNAL OF CHROMATOGRAPHY A, 2003, 989 (01) :155-163
[5]  
Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037
[6]   Modern plasma fractionation [J].
Burnouf, Thierry .
TRANSFUSION MEDICINE REVIEWS, 2007, 21 (02) :101-117
[7]   Improving the efficacy of antibody-based cancer therapies [J].
Carter, P .
NATURE REVIEWS CANCER, 2001, 1 (02) :118-129
[8]   Therapeutic antibodies for autoimmunity and inflammation [J].
Chan, Andrew C. ;
Carter, Paul J. .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (05) :301-316
[9]   PEGylated antibodies and antibody fragments for improved therapy: a review [J].
Chapman, AP .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) :531-545
[10]  
Christ O, 2001, CLIN CANCER RES, V7, P985